Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), today announced several steps it is taking to improve costs and transparency around pharmacy benefits. These changes aim to help ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Hosted on MSN14d
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%According to the FTC report, UnitedHealth’s OptumRx, along with Cigna’s Express Scripts and CVS Caremark Rx, were able to collectively pocket $7.3 billion in added revenue above cost during the five ...
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback